Knight Therapeutics Revenue and Competitors

Knight Therapeutics Inc. (TSX: GUD) is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products in Canada and select international markets. In addition, Knight conducts late-stage clinical development on low risk, low expense product opportunities. All of Knight’s products are sourced through partnerships.\r\n\r\nUnlike many other specialty pharmaceutical companies, Knight has the flexibility to explore opportunities in a range of therapeutic areas.